Delivery Order SPE2DB25D1258-SPE2DB25F06G4
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,564.66 to AmerisourceBergen Drug Corp on July 20, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order was placed at...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, awarded on July 22, 2025, represents a non-competitive award under the company's existing indefinite delivery contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $639,741.96 to AmerisourceBergen Drug Corp on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued as a child contract under AmerisourceBergen's larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $386,479.07 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price, non-set-aside contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The Defense Logistics Agency awarded a $66,068 delivery order to AmerisourceBergen Drug Corp under a firm fixed-price contract, with performance in Conshohocken, Pennsylvania and an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded delivery order represents a call against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,192.65 to AmerisourceBergen Drug Corp on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $738,830.10 to AmerisourceBergen Drug Corp on September 6, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price delivery order, which is not set-aside, leverages AmerisourceBergen's position as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $387,190.90 to AmerisourceBergen Drug Corp on July 28, 2025, under a firm fixed-price contract type. The contract, which is a child order under AmerisourceBergen's larger Pharmaceutical Prime Vendor Global Program IDC, is scheduled for completion by July 29, 2025. No set-aside designation was used in this competitive award, and performance will take place at AmerisourceBergen's corporate office in...
- SPE2DB25D1258Indefinite Delivery Contract
- SPE2DB25D1258-SPE2DB25F06G4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,257.36 to AmerisourceBergen Drug Corp on July 29, 2025, under a firm fixed-price contract with an ultimate completion date of July 30, 2025. This non-set-aside award is issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical distributor for federal medical procurement needs across the military and veteran healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing an extensive portfolio of medical products through federal contracts with the DLA Medical Supply Chain, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As the prime contractor on this delivery order, AmerisourceBergen supplies medical products to support Defense Health Agency operations and other government healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative plans to establish multiple regional contracts with separate contractors, positioning AmerisourceBergen as one of the key vendors in this strategic approach to global pharmaceutical support for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/29/25 |